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a b s t r a c t
Male Ppp1cc knockout mice are infertile due to failure of spermatogenesis, thought to arise
from a deﬁciency of the predominant testis isoform PPP1CC2. We hypothesize that sub-
strates of the PPP1CC2 will be hyperphosphorylated in Ppp1cc mutant testes. Quantitative
RT-PCR and histological data suggest a role for PPP1CC2 by 3 weeks of age in the testis.
Comparative phosphoproteomic analysis identiﬁed 828 proteins phosphorylated in the 3eywords:
permatogenesis
hosphatase
week mouse testis, and conﬁdently assigned 1026 unique phosphorylation sites. Thirty-two
peptides corresponding to 30 proteins were found to be more abundant in Ppp1cc mutant
samples than in wild-type, representing candidate substrates of PPP1CC2.
© 2013 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA).
that PPP1CC2 is the predominant isoform in the mouse testis
Open access under CC BY-NC-ND license.hosphoproteomics
. Introduction
rotein phosphorylation is a critical intracellular signaling
echanism that plays a role in the regulation of countless cel-
ular processes. Spermatogenesis is no exception; in fact, next
o the brain, the testis contains more tissue speciﬁc phosphor-
lation sites than any other tissue studied [1,2]. There exist
xamples of both kinases (such as TSSK1/TSSK2 [3,4], TSSK6
5], LMTK2 [6]) and phosphatases (PPP1CC2 [7], MTMR2 [8])
hich are indispensable to spermatogenesis. Thus, in the case
f the Ppp1cc knockout mouse, it is hypothesized that a loss
f phosphatase activity towards a speciﬁc substrate or sub-
trates causes failure of spermatogenesis. Targeted deletion
f Ppp1cc in mice results in the widespread loss of developing
∗ Corresponding author. Tel.: +1 416 978 2759.
E-mail address: s.varmuza@utoronto.ca (S. Varmuza).
212-9685 © 2013 The Authors. Published by Elsevier B.V. on behalf of European Proteo
ttp://dx.doi.org/10.1016/j.euprot.2013.11.009germ cells most prominently from the elongating spermatid
stage onwards [7]. Ppp1cc mutant seminiferous tubules appear
to display a bottleneck in spermatogenesis that results in
a disorganized seminiferous epithelium [9]. Surviving germ
cells display a wide range of abnormalities including defects
in chromatin condensation and acrosomal biogenesis [7,9].
Ppp1cc is a member of the PP1 family of Ser/Thr protein phos-
phatases, which includes three different genes in mammals,
Ppp1ca, Ppp1cb and Ppp1cc. The Ppp1cc knockout mouse lacks
the expression of two different splice isoforms, the ubiquitous
Ppp1cc1 and the testis-speciﬁc Ppp1cc2. Studies have indicatedalthough other PP1 isoforms are expressed [7,10]. A recent
transgenic rescue experiment has established that expres-
sion of the PPP1CC2 isoform alone is able to rescue the Ppp1cc
mics Association (EuPA). Open access under CC BY-NC-ND license.
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mutant infertility phenotype, provided expression levels sur-
pass a threshold amount [11].
While the requirement of PPP1CC2 for completion of mam-
malian spermatogenesis is well established, its exact role(s)
has yet to be elucidated. To date, a number of PPP1CC2 inter-
acting proteins in the testis have been identiﬁed [12–19],
including most recently, DDOST [20], TSKS and TSSK1 [21];
however the identiﬁcation of bona ﬁde PPP1CC2 substrates
has proven to be challenging, as the interaction between PP1
isoforms and their substrates is typically weak, and short-
lived. Ppp1cc mutant testes are lacking expression of a protein
phosphatase gene, meaning that PPP1CC2 is unavailable for
substrate dephosphorylation. Therefore, by identifying hyper-
phosphorylated testis expressed proteins in a Ppp1cc mutant
background we can identify candidate substrates of PPP1CC2
that may play a crucial role in spermatogenesis. Previous
research from our laboratory performed 2-dimensional elec-
trophoresis (2DE) coupled with phosphoprotein staining to
identify hyperphosphorylated proteins in the Ppp1cc mutant
testis [17]. This approach identiﬁed several candidate PPP1CC2
substrates, including HSPA2 and -tubulin. In the present
study we have expanded upon this line of inquiry by mak-
ing several key changes to our methodology. First, although
the use of 2DE is a dependable method of protein sepa-
ration, its use in proteomics is compromised by the fact
that it requires the excision of individual spots on a gel. In
contrast, LC–MS/MS based methods coupled with phospho-
peptide enrichment can simultaneously identify numerous
phosphopeptides from a single sample, and can also iden-
tify the speciﬁc site of phosphorylation. Phosphopeptide
enrichment strategies such as immobilized metal ion chro-
matography (IMAC), and TiO2 chromatography have been
demonstrated to be highly effective in identifying phosphor-
ylation sites via LC–MS/MS from rodent testis samples [1,2].
Similar approaches have been used successfully to analyze
phosphopeptide changes during rat sperm capacitation, and
epididymal maturation, with as little as 150g of starting
material [22,23].
A second major methodological change relates to the tis-
sue samples analyzed.Our previous testis phosphoproteomics
study [17] used testis proteins from adult mice for their anal-
ysis. However, the composition of the wild-type adult testis
is very different from the Ppp1cc mutant, as the latter suf-
fers from a near complete lack of cells from the elongating
spermatid phase onwards [7]. The proteomes of different
spermatogenic cell types are quite different [24,25], and by
extension their phosphoproteomes. Thus, many observed
changes in protein phosphorylation status are likely due to
secondary effects. To ensure that phosphoproteomic analysis
reﬂects changes due speciﬁcally to a loss of PPP1CC activ-
ity, and not secondary effects, we have opted to focus on the
time-point that the Ppp1cc gene is ﬁrst required in the testis.
Previous work from our laboratory indicated that the ﬁrst
observable Ppp1cc knockout phenotype occurs around 3 weeks
of age, when pubertal testes have proceeded part way through
the ﬁrst wave ofmeiosis [26]. To verify this observationwe per-
formed an analysis of the expression of all four PP1 isoforms in
the mouse testis to testis for the earliest incidence of Ppp1cc2
speciﬁc upregulation and performed a phenotypic compari-
son of wild-type and Ppp1cc mutant seminiferous tubules ats 2 ( 2 0 1 4 ) 1–16
this time point prior to conducting a comparative phospho-
proteomic analysis.
2. Materials and methods
2.1. RNA extraction and cDNA synthesis
Testis and brain samples were homogenized in Trizol®
Reagent (Invitrogen) and RNA was extracted using the man-
ufacturer’s suggested protocol. RNA quality was assayed via
gel electrophoresis with examination of the 16S and 18S
rRNA bands. RNA purity and yield were determined using
a nanodrop spectrophotometer (Fisher Scientiﬁc). Following
RNA extraction, samples were diluted to 1g/L in ultrapure
H2O. For cDNA synthesis 5g of RNA was treated with DNAse
I in the presence of RiboLockTM RNAse inhibitor (Thermo Sci-
entiﬁc), followed by reverse transcription using 20 units of
M-MuLV (Fermentas) with 100ng random hexamer primers
(Fermentas) for 1h at 50 ◦C. Resultant cDNA was diluted in
ultrapure H2O.
2.2. Quantitative PCR
Two primer pairs were utilized in qPCR experiments for each
transcript tested; an “outside” primer pair for production of
template DNA for standard curve production, and an “inside”
primer pair for the qPCR reaction itself. Primer pairs used in
this experiment are listed in Table 1. qPCR was performed
using SYBR® Advantage® qPCR Premix (Clontech) according to
the provided protocol. Reactions were carried out in a Rotor-
gene 3000 Light Cycler (Corbett Research) and analyzed using
the accompanying software. Following an initial denaturation
period of 30 s at 95 ◦C, PCR cycling conditions were as follows:
denaturation for 5 s at 95 ◦C; annealing for 20 s at 55 ◦C for
actin, 53 ◦C for Ppp1ca and Ppp1cb, 56.1 ◦C for Ppp1cc1, 53.7 ◦C
for Ppp1cc2; extension for 30 s at 72 ◦C for a total of 40 cycles.
Normalized Ppp1c expression levels were calculated by divid-
ing raw Ppp1c values by the average of 2 Actb qPCR runs for a
given cDNA sample. Analysis was performed on cDNA sam-
ples from 3 different mice at each age, with duplicate qPCR
runs performed on each sample. Exceptions to this sample
size include Ppp1cc2 1 week sample, where an outlier (∼100×
all other samples at that age point) was discarded and Ppp1cb 5
week sample where only two samples were available. Relative
Ppp1c expression levels from duplicates were averaged prior to
statistical analysis.
2.3. Statistical analysis of qPCR data
To test for signiﬁcant changes in Ppp1c isoform expression lev-
els throughout post-natal development a one-way analysis of
variance (ANOVA) was performed with the aid of Microsoft
Excel. ANOVAs were followed by Tukey’s post-tests, performed
manually, to conduct pairwise comparisons of expressiondata
fromdifferent age groups. Newman–Kuelsmultiple range test,
and pairwise t-tests were also performed on selected samples
where indicated.
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Table 1 – Primers used for qPCR analysis of PP1 isoform expression in the post-natal mouse testis.
Transcript Outside/inside Forward primer sequence Reverse primer sequence
Actb Outside ATGAAGATCCTGACCGAGCG TACTTGCGCTCAGGAGGAGC
Actb Inside GACGGCCAGGTCATCACTAT GCACTGTGTTGGCATAGAGG
Ppp1ca Outside CAGCCATTGTGGATGAGAAG TTTCTTGGCTTTGGCAGAAT
Ppp1ca Inside TTGCCAAGAGACAGTTGGTG ACTGCCCATACTTGCCCTTA
Ppp1cc1 Outside GTTTTAACTGCTTGCCGATAGC CTGAATGGACGGGTTCAGG
Ppp1cc1 Inside CCCATCAGGTGGTTGAAGAT CTGAATGGACGGGTTCAGG
Ppp1cc2 Outside GTTTTAACTGCTTGCCGATAGC GCCTGATCCAACCCGTGG
TCAG
AGCA
ACGA
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.4. Histology
estes from3week oldwild-type and Ppp1ccmutantmicewere
issected and ﬁxed in Bouin’s solution overnight at 4 ◦C fol-
owed by dehydration in a graded series of ethanol solutions
nd embedding in TissuePrep® (Fisher Scientiﬁc). Seven m
ections were dewaxed, hydrated and stained using the Peri-
dic Acid-Schiff (PAS) staining system (Sigma–Aldrich) with
aematoxylin counterstaining. Slides were mounted in 50%
lycerol for viewing with an Olympus BX60 microscope and
mages were captured using Cool Snap software and a CCD
amera (RSPhotometrics). Images were adjusted for bright-
ess and contrast using Photoshop 6.0 (Adobe).
.5. Phosphopeptide enrichment
ouse testes were decapsulated, homogenized in 400L
f freshly prepared 7M urea, 4% CHAPs (w/v), 40mM Tris
nd DNAseI and incubated with rocking at 4 ◦C for 30min.
xtracted proteins were reduced with 20mM dithioreitol for
h at room temperature followed by alkylation with 40mM
odoacetic acid for 35min at room temperature in darkness.
estis proteins were precipitated with acetone and dried
sing a speed vac. Dried acetone pellets were resuspended
n 1M urea, 50mM ammonium bicarbonate and concentra-
ion was determined using the BCA Protein Assay Kit from
io Basic Inc. Trypsin digestion of testis protein was carried
ut overnight with proteomics grade trypsin (Sigma–Aldrich
6765) (trypsin:protein ratio 1:50) at room temperature with
nd over end rotation. Digestion was subsequently acidiﬁed
ith 1% (v/v) formic acid and centrifuged to remove insolu-
le material. 120g testis peptides were then was used for
hosphopeptide enrichment via sequential elution from IMAC
SIMAC) using the protocol modiﬁed from Thingholm et al.
35,36]. Brieﬂy, peptides dried using a speed-vac and then
ere resuspended in ∼300L of IMAC loading buffer (50%
cetonitrile, 0.1% TFA) and incubated with 40L of washed
HOS-selectTM IMAC resin (Sigma–Aldrich) for 30minwith end
ver end rotation. IMAC resin was packed into a 200L gel
oading pipette tip, and washed with 150L of IMAC load-
ng buffer. A ﬁrst phosphopeptide elution step was conducted
ith 140L of acidic elution buffer (1% TFA, 20% acetonitrile)
ollowed by a second elutionwith 160L of basic elution buffer
ammonia water). The basic elution fraction was acidiﬁed
ith 10L of formic acid and lyophilized. IMAC ﬂow through
and wash) and acidic elution fraction were also lyophilized,
ollowed by resuspension in 250L TiO2 loading buffer (80%GTGGTTGAAGAT GCCTGATCCAACCCGTGG
TCAAATCGCATTT TCGGTGGATTAGCTGTTCG
CAGTTGGTAACCTT TCGGTGGATTAGCTGTTCG
acetonitrile, 5% TFA, 1M glycolic acid). Resuspended peptides
were incubated with 50L of washed TiO2 Mag SepharoseTM
(GE Healthcare) for 30min with end over end rotation. TiO2
resinwaswashed sequentiallywith 500L TiO2 loading buffer,
80L of 80% acetonitrilewith 1%TFA and 80L of 10% acetoni-
trilewith 0.2%TFA. After 10min of air drying phosphopeptides
were eluted fromTiO2 resin by incubationwith 50L ammonia
water for 5min with constant mixing. Eluted phosphopeptide
solution was acidiﬁed with 2L of 10% TFA and 7L of formic
acid. For each individual mouse the TiO2 enriched IMAC ﬂow
through and acidic elution fractions were then combined and
lyophilized.
2.6. LC–MS/MS analysis
The digested peptides were loaded onto a 100m ID×2 cm
(3m C18) pre-column (Thermo-Fisher Scientiﬁc) at 4L/min
and separated over a 75m ID×15 cm (2m C18) analyt-
ical column (EASY-Spray, Thermo-Fisher Scientiﬁc, Odense
Denmark). The peptideswere eluted over 60min at 300nl/min.
using a 0–40% acetonitrile gradient in 0.1% formic acid using
an EASY nLC 1000 nano-chromatography pump (Thermo-
Fisher Scientiﬁc, Odense Denmark). The peptides were eluted
into a LTQ Velos-Orbitrap Elite hybrid mass spectrometer
(Thermo-Fisher, Bremen, Germany) operated in a data depen-
dant mode. MS was acquired at 240,000 FWHM resolution in
the FTMS (using a target value of 5×105 ions) and MS/MS
was carried out in the linear ion trap. Ten MS/MS scans
were obtained per MS cycle using a target of 1×104 ions
and a maximum injection time of 50ms, all ions passing
the monoisotopic precursor selection (MIPS) ﬁlter were frag-
mented and the multistage activation option was used. The
raw data ﬁles were searched using Proteome Discover 1.3
(Thermo-Fisher Scientiﬁc) using a parent ion accuracy of
10ppm and a fragment accuracy of 0.6Da A ﬁxed modiﬁca-
tion of carbamidomethyl cysteine and variable modiﬁcations
of phosphorylated serine, threonine and tyrosine residues, as
well as oxidized methionine were considered in the search.
2.7. Database searching
All MS/MS samples were analyzed using Sequest (Thermo
Fisher Scientiﬁc, San Jose, CA, USA; version 1.3.0.339)
and X! Tandem (The GPM, thegpm.org; version CYCLONE
(2010.12.01.1)). Sequest was set up to search MOUSE-Uniprot-
Sep-05-12.fasta (unknown version, 55,250 entries) assuming
the digestion enzyme trypsin. X! Tandem was set up to search
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the MOUSE-Uniprot-Sep-05-12 database (unknown version,
55,270 entries) also assuming trypsin. Sequest and X! Tandem
were searched with a fragment ion mass tolerance of 0.60Da
and a parent ion tolerance of 10.0 PPM. Carbamidomethyl of
cysteine was speciﬁed in Sequest and X! Tandem as a ﬁxed
modiﬁcation. Glu→pyro-Glu of the n-terminus, ammonia-
loss of the n-terminus, gln→pyro-Glu of the n-terminus,
oxidation of methionine and phospho of serine, threonine
and tyrosine were speciﬁed in X! Tandem as variable mod-
iﬁcations. Oxidation of methionine and phospho of serine,
threonine and tyrosine were speciﬁed in Sequest as variable
modiﬁcations.
2.8. Criteria for protein identiﬁcation
Scaffold (version Scaffold 4.2.1, Proteome Software Inc., Port-
land, OR) was used to validate MS/MS based peptide and
protein identiﬁcations. Peptide identiﬁcations were accepted
if they could be established at greater than 95.0% probability
by the Peptide Prophet algorithm [27]. Peptide identiﬁcations
were also required to exceed speciﬁc database search engine
thresholds. Sequest identiﬁcations required at least deltaCn
scores of greater than 0.10 and XCorr scores of greater than
1.8, 2.5, 3.5 and 3.5 for singly, doubly, triply and quadruply
charged peptides. X! Tandem identiﬁcations required at least
−Log(Expect Scores) scores of greater than 0.00. Protein identi-
ﬁcations were accepted if they could be established at greater
than 90.0% probability and contained at least 1 identiﬁed pep-
tide. Protein probabilitieswere assigned by the Protein Prophet
algorithm [28]. Proteins that contained similar peptides and
could not be differentiated based on MS/MS analysis alone
were grouped to satisfy the principles of parsimony. Assign-
ment of phosphorylation to speciﬁc siteswas performed using
Scaffold PTM (version 2.0.0, ProteomeSoftware)which is based
on the Ascore algorithm [29]. Scaffold PTM re-analyzes search
engine results to ﬁnd the best match for the observed spec-
trum to a PTM site by comparing site-determining ions, and
producing Ascore results assigning an ambiguity score to each
reported PTM site. The cut-off value for conﬁdent phosphory-
lation site assignment was a 95% localization probability.
2.9. Bioinformatic and semi-quantitative analysis of
testis phosphoproteins
Enrichment analysis was performed on identiﬁed testis phos-
phoproteins using the DAVID Functional Annotation Chart
tool from the DAVID Bioinformatics Resources 6.7 [30,31] using
theMusmusculus background andqueried for GO cellular com-
ponent, biological process andmolecular function. Knownand
predicted PP1 interacting proteins were identiﬁed using PSIC-
QUIC [32] and I2D [33,34] (mouse as target organism) search
tools. Annotation of identiﬁed phosphopeptides to the GO
biological process reproduction (GO:0000003) was performed
using the Scaffold viewer software. Spectral counting of indi-
vidual phosphorylation sites was performed using data from
Scaffold PTM assigned sites only, which were present in at
least 2 of 3 replicates of at least one genotype. A cut-off value
of 2 was used as a minimal fold-change required for further
analysis.s 2 ( 2 0 1 4 ) 1–16
2.10. MS1 ﬁltering and quantitative analysis of testis
phosphopeptides
MS1 ﬁltering quantitative analysis of extracted ion chro-
matograms was performed using Skyline [35] according to
the step by step instructions available on the Skyline web-
site (http://proteome.gs.washington.edu/software/Skyline/
tutorials/ms1ﬁltering.html). A spectral library was ﬁrst cre-
ated using Mascot .DAT ﬁles (Matrix Sciences, London, UK)
from all six replicate MS/MS runs described above using a
cut-off score of 0.8. The Skyline peptide tree was populated
with candidate hyperphosphorylated peptides identiﬁed in
the preliminary analysis described above by either importing
speciﬁc peptide sequences, or full protein FASTA sequences
retrieved using the Uniprot retrieval tool. Results for MS1
ﬁltering were imported from raw ﬁles for all six samples using
an import ﬁlter resolution of 100,000. Skyline automated
peak selection was manually adjusted when clear outliers
in retention time were observed in replicate results. XIC
peak area values were exported from Skyline into Microsoft
Excel and were log2 transformed and subjected to statistical
analysis using a student’s t-test (p≤0.05).
3. Results
Expression of Ppp1ca, Ppp1cb, Ppp1cc1, and Ppp1cc2 was
detectable in mouse testis cDNA ranging from 1 to 5 weeks of
age. In addition, Ppp1ca and Ppp1cc1 were detectable in brain
cDNA, whereas little or no Ppp1cc2 expression was evident
(level of expression was outside the range of the standard
curve) and Ppp1cbwasnot assayed. The levels of Ppp1ca, Ppp1cb
and Ppp1cc1 transcripts displayed no signiﬁcant difference in
expression level throughout theﬁrstwaveof spermatogenesis,
or between brain and testis cDNA samples (Fig. 1). In contrast,
ANOVAanalysis of Ppp1cc2 transcript levels showeda clear and
statistically signiﬁcant increase in expression level through-
out the ﬁrstwave of spermatogenesis (p=0.001) (Fig. 1). Ppp1cc2
expression levelwas lowat 1 and 2weeks of age. Subsequently,
at three weeks of age the level of Ppp1cc2 increased approx-
imately 6-fold, which is a statistically signiﬁcant increase
relative to the 2 week time point (p<0.001). By four weeks of
age Ppp1cc2 transcript levels had again signiﬁcantly increased
(p=0.02) a further 2.5-fold. By the fourweek time point Ppp1cc2
expression level had reached its maximum level by the end
of the ﬁrst-wave of spermatogenesis, as no signiﬁcant change
was evidenced at the 5 week time point. These data show con-
clusively that the Ppp1cc2 transcript speciﬁcally is upregulated
in the mouse testis starting at 3 weeks of age.
3.1. The seminiferous epithelium of 3 week old Ppp1cc
mutant mice displays impaired spermatogenesis
To test if the upregulation of Ppp1cc2 in the mouse testis at 3
weeks of age corresponds to a requirement of PPP1CC2 for nor-
mal spermatogenesis, we examined the seminiferous tubules
of wild-type and Ppp1cc mutant mice. Previous research has
observed the ﬁrst phenotypic effects of the Ppp1cc mutant to
be visible at this stage [25], which we sought to conﬁrm before
progressing with further experiments. While the ﬁrst wave
e u pa open proteomics 2 ( 2 0 1 4 ) 1–16 5
Fig. 1 – Expression of mouse Ppp1c isoforms in the testis during the ﬁrst wave of spermatogenesis. Time points listed are
weeks post-natal. Expression levels from brain were from whole adult tissue. Values are relative to -actin×1000. *
indicates a statistically signiﬁcant (˛=0.05) change in expression level from the previous time point. Note that in the brain,
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bpp1cb levels were not tested, and Ppp1cc2 levels were tested
f spermatogenesis is commonly referred to as synchronous,
ur observations suggest that there is some variation in tim-
ng, consistent with previous work from our lab [25]. By three
eeks of age, most wild-type mouse seminiferous tubules
re in the ﬁnal stages of meiosis and the remainder contain
he ﬁrst round spermatids (Fig. 2A). Wild-type seminiferous
ubules generally display a uniform thickness with very few
bserved instances of cell sloughing (Fig. 2C). Progression of
permatogenesis does not appear to be impaired in Ppp1cc
utant seminiferous tubules as both tubules containing late
permatocytes and round spermatids were visible (Fig. 2B).
hile a substantial proportion of Ppp1cc mutant seminifer-
us tubules display normal morphology, many others display
bnormalities including an increase in cell sloughing and
acuolation (Fig. 2B). A closer examination of the seminif-
rous epithelium inside Ppp1cc mutant seminiferous tubules
eveals a number of reoccurring defects including cell slough-
ng (Fig. 2D), joined round spermatid nuclei within a single
ytoplasm (Fig. 2E, arrows), and prominent “blobs” of cellular
aterial projecting into the tubule lumen (Fig. 2F, arrowhead).
hese results indicate that while there is no block in the
rogression of spermatogenesis, there is impairment in the
rocess by three weeks of age in response to the loss of Ppp1cc.
urthermore,while there is evidence of cell loss at this age, the
ellular composition of wild-type and Ppp1cc mutant seminif-
rous tubules is very similar.
.2. Phosphoproteomic analysis of the 3 week mouse
estis
fter determining that Ppp1cc is ﬁrst required in the testis
y 3 weeks of age we sought to achieve two goals viabelow the level of quantitation.
phosphoproteomic analysis. First, we wanted to identify as
many phosphoproteins in the 3 week testis as possible. These
proteinswould serve as a resource to others interested in PTMs
during testis development, as well as representing a large pool
of potential PPP1CC1/PPP1CC2 substrates for further bioinfor-
matic analysis. Our second and ultimate goal was to identify
proteins that were differentially phosphorylated in wild-type
and Ppp1cc mutant 3 week testes. Those proteins that are
hyperphosphorylated on Ser/Thr residues in Ppp1cc mutants
would represent strong candidate PPP1CC2 testis substrates.
Phosphopeptide enrichment of 3 week mouse testis pep-
tide samples was performed using a modiﬁed sequential
elution from IMAC (SIMAC) [36,37] strategy. The SIMACmethod
includes an initial phosphopeptide enrichment using IMAC, in
which bound peptides are sequentially eluted with an acidic
and basic solution. Next the IMAC ﬂow-through and acidic
elution are subjected to a second phosphopeptide enrich-
ment step using TiO2 chromatography. Using our conditions,
the TiO2 enriched fractions yielded 95% phosphopeptides.
However, the IMAC basic elution fraction contained only 15%
phosphopeptides. For this reason, we proceeded using only
the combined TiO2 enriched fractions.
Phosphopeptide enriched samples from three biological
replicates each of 3 week old wild-type and Ppp1cc mutant
testiswere thenanalyzedvia LC–MS/MSusinganLTQ-Orbitrap
elite to identify the phosphopeptides present. Peptide full
peptide report data from Scaffold can be found in Supplemen-
tary ﬁle S1, and phosphorylation site assignment data from
Scaffold PTM can be found in Supplementary ﬁle S2. These
data have been uploaded to the Global Proteome Machine
website (http://review.thegpm.org/review/index.html and
can be accessed using the following accession numbers
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Fig. 2 – Phenotypic abnormalities are present in the seminiferous tubules of 3 week old Ppp1cc mutant mice. Heterozygous
seminiferous tubules (A and C) retain the vast majority of developing germ cells and present a consistent and normal
morphology. In Ppp1cc mutant testes phenotypically normal and abnormal seminiferous tubule phenotypes are often
evident within the same cross-section (B). A number of phenotypic abnormalities are visible in Ppp1cc mutant seminiferous
tubules including germ cell sloughing (B, asterisk and D) multiple spermatid nuclei joined closely together (E, arrows) and
large “blobs” of cellular material projecting into the tubule lumen (F, arrowhead).– Mut1: GPM77700020781, Mut 2: GPM00300024842,
Mut 3: GPM77700020782, WT1: GPM77700020783, WT2:
GPM77700020784, WT3: GPM77700020785) and will be made
publicly available following publication of our work. In total
11,554 spectra mapping to phosphopeptide were identiﬁed,
corresponding to 828 different proteins and 1026 different
phosphorylation sites. Searching spectra against a decoy
database revealed 0.61% false discovery rate. Fifteen percent
more phosphopeptide spectra were detected in the Ppp1cc
mutant samples when compared to the wild-type, however
this increase was not statistically signiﬁcant (p=0.17). Our
phosphopeptide enrichment strategy was reproducible at a
qualitative level as was evidenced at the protein level with a
signiﬁcant degree of overlap between wild-type and Ppp1cc
mutant samples, as well as between biological replicateswithin the same group. Six hundred and four (590) different
proteins were identiﬁed in wild-type samples and 682 were
identiﬁed in Ppp1cc mutant samples. Of these proteins, 444
were identiﬁed in at least one biological replicate of each
genotype, 146 were unique to wild-type and 238 were unique
to Ppp1cc mutants (Fig. 3A). The vast majority of proteins
unique to either wild-type or Ppp1cc mutant samples were
identiﬁed by a small number of spectra, often a single spec-
tra, and are not abundant in the phosphopeptide dataset.
Forty-three percent of phosphorylated proteins detected in
wild-type samples were detected in all 3 biological replicates
and 61% were found in more than one replicate (Fig. 3C).
In Ppp1cc mutant samples, 39% of phosphorylated proteins
detected were found in all 3 biological replicates, and 64%
were found in at least 2 replicates (Fig. 3D). At the peptide
e u pa open proteomics 2 ( 2 0 1 4 ) 1–16 7
Fig. 3 – Reproducible phosphopeptide enrichment and identiﬁcation in wild-type and Ppp1cc mutant testis samples. (A)
Venn diagram depicting the number of unique phosphoproteins identiﬁed in each genotype examined. (B) Venn diagram
depicting the number of unique phosphopeptides identiﬁed in each genotype examined. (C) Venn diagram depicting the
inter-sample reproducibility at the protein level in wild-type testis samples. Triangle represents proteins found in at least 2
of 3 replicates, which were subsequently considered for quantitative analysis via spectral counting. (D) A similar Venn
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evel 1578 unique phosphopeptides (meaning amino acid
equence, ignoring phosphorylation site assignment) were
dentiﬁed, 790 of which were found in both wild-type and
pp1cc mutant testis samples (Fig. 3B). Amongst the identiﬁed
estis phosphoproteins were 40 proteins encoded by genes for
hich male infertility mouse models exist. As well, we have
ound 21 known PP1 interacting proteins (or approximately
0% of all known interactors) and 8 predicted PP1 interacting
roteins to be phosphorylated in the 3 week mouse testis
Supplementary ﬁle S3), including at least 4 known PP1
ubstrates: RB1, SRSF10, SF3B1 and PPP1R2. Eleven different
roteins that were identiﬁed in SBP-3XFLAG-PPP1CC2 ES cell
andem afﬁnity puriﬁcation [20], as well as the OST complex
rotein STT3B were also identiﬁed in our phosphoproteomic
ataset (Supplementary ﬁle S3).
Supplementary material related to this article can
e found, in the online version, at doi:10.1016/j.euprot.
013.11.009.
To further deﬁne the overall characteristics of the 3
eek testis phosphoproteome, we performed a bioinformatic
nalysis using the DAVID Functional Annotation Tool to iden-
ify GO Cellular Compartment, Functional Annotation, and
iological Process terms enriched in our dataset (full list
n Supplementary ﬁle S4). GO cellular compartment anal-
sis showed enrichment for a number of compartmentssamples.
including chromosome/chromatin, ribonucleoprotein com-
plexes and the cytoskeleton.DNA, RNAand chromatin binding
proteins, serine/threonine kinases and transcription factor
binding proteins were all highly enriched via GO molecular
function analysis. The most highly enriched biological pro-
cesses in the 3 week mouse testis phosphoproteome included
RNA processing, chromatin organization and the cell cycle,
with meiosis and spermatogenesis also being signiﬁcantly
enriched. These functional characteristics are not unexpected
given our knowledge of this tissue at this particular point in
development, where intensive reorganization of the nuclear
material is underway in the majority of cells, and cytoskeletal
reorganization is primed to begin in newly emerging cells.
Supplementary material related to this article can
be found, in the online version, at doi:10.1016/j.euprot.
2013.11.009.
3.3. Semi-quantitative comparison of wild-type and
Ppp1cc mutant testis phosphoproteomes
In order to examine changes in protein phosphorylation status
in response to the Ppp1cc deletion it is necessary to examine
our results at the peptide level, as it is the phosphoryla-
tion stoichiometry at speciﬁc sites that will yield candidate
substrate identiﬁcation. Label-free quantitative analysis was
8 e u pa open proteomic
Fig. 4 – Strategy for quantitative analysis of wild-type and
Ppp1cc mutant 3 week testis phosphoproteomes. After
phosphopeptide enrichment via IMAC and TiO2
chromatography, peptides were subjected to LC–MS/MS
analysis. MS/MS data was used for preliminary
identiﬁcation of candidate hyperphosphorylated peptides
via spectral counting, MS/MS peak XIC quantitation as well
as peptides from genes essential for male fertility,
associated with the GO biological process Reproduction,
and encoding known or predicted PP1 interacting proteins
(PIPs). Candidate peptides were then subjected to MS1
ﬁltering using Skyline to compare XIC quantitative
across all six replicates using the Skyline MS1 ﬁltering toolmeasurements from MS data across all six replicates.
performed on the three biological replicates of each geno-
type and subjected to both spectral counting and extracted
ion chromatogram quantitation. Our quantitative analysis
strategy consisted of two stages, a preliminary stage where
candidate peptides were identiﬁed for closer inspection, fol-
lowed by a thorough quantitative analysis of the candidate
peptides using MS1 ﬁltering of extracted ion chromatograms
across all six replicates (Fig. 4).
Spectral counting is a semi-quantitative measure based
on the correlation between the abundance of a protein and
the frequency of sampling of precursor ions in an LC–MS/MS
experiment [38]. As a ﬁrst approach in our preliminary quan-
titative analysis of the 3 week testis phosphoproteome we
used the Scaffold PTM software (version 2.0.0, Proteome Soft-
ware Inc., Portland, OR) which reanalyzes MS/MS results using
an extension of the Ascore algorithm to produce conﬁdent
PTM site assignments. Hence, we were able to conﬁdently
assign 1026 unique phosphorylation sites (923 serine, 97 thre-
onine and 6 tyrosine) in 572 different proteins throughout our
6 replicates. To identify candidate hyperphosphorylated pro-
teins in 3 week Ppp1cc mutant testes searched our dataset
for phosphorylation sites that were (a) present in at least 2
of 3 biological replicates of at least one genotype, and (b)
exhibited at least a 2-fold increase in spectral count in Ppp1cc
mutant replicates (Fig. 5A). This analysis yielded phosphory-
lation sites in 145 different proteins that were more abundant
in Ppp1ccmutants (Supplementary ﬁle S5). Amongst these pro-
teins were at least two known PP1 interacting proteins; MAP1B
[39,40] and NCL (Nucleolin) [41], one known substrate, SF3B1
[42] as well as 12 proteins encoded by genes which, when
deleted, result in infertility in mice (ESPL1, TDRD1, SYCP3,
AGFG1, CCNE2, ADAM2, HMGA1, CLGN, CSDA, SYCP2, RAD18
and HSPA4). As mentioned above, spectral counting is con-
sidered to be a semi-quantitative analytical method, and is
subject to an increased amount of variation when dealing
with low spectral count numbers as is the case for many ofs 2 ( 2 0 1 4 ) 1–16
the phosphopeptides observed in this study. Therefore, these
peptides require further analysis to determine if they are truly
hyperphosphorylated in Ppp1cc mutants, such as examination
of precursor ion intensity.
Supplementary material related to this arti-
cle can be found, in the online version, at
doi:10.1016/j.euprot.2013.11.009.
To complement our preliminary spectral counting analysis
of the 3 week mouse testis phosphoproteome, we next per-
formed a second preliminary quantitative analysis approach,
this time based on the extracted ion chromatograms (XIC) of
phosphopeptides. The signal intensity of a given peptide in an
LC–MS run is proportional to its abundance; thus, by extract-
ing the area under to curve of a peptide peak (XIC value) in
a number of samples we can compare its abundance [43].
For this approach, we compared the average log2 transformed
XIC values for all phosphopeptides detected in the SEQUEST
database search between wild-type and Ppp1cc mutant testis
samples (Fig. 5B). To reduce the effect of outliers and allow
for statistical analysis we only considered peptides that were
present in at least 2 of 3 biological replicates for each geno-
type. Both a two sample student’s t-test (when 3 replicate
values of each genotype were available) and a local-pooled
error test (LPE) [44,45] were conducted to detect peptides that
differed in abundance in Ppp1cc mutant 3 week testis. This
analysis identiﬁed 40 different phosphopeptides that were
more abundant in Ppp1cc mutant samples, corresponding to
36 unique proteins (Supplementary ﬁle S5), seven of which
were also identiﬁed via spectral counting (ACIN1, ENTHD1,
ESPL1, HNRNPU, LARP1, RALY, and SYCP2). The preliminary
quantitative analysis described above suffers from one key
limitation; XIC values for only those peptide ions that were
subsequently selected for MS/MS fragmentation are available.
Thus, a large amount of information remains unexplored in
the LC–MS data, and peptides identiﬁed as more abundant
in mutant testes by these means require further analysis as
conﬁrmation by looking at precursor ion intensities across all
samples.
3.4. Identiﬁcation of hyperphosphorylated proteins in
the 3 week Ppp1cc mutant testis via label-free
quantitative analysis
Preliminary quantitative analysis of the 3 week Ppp1cc
mutant testis phosphoproteome provided a list of candi-
date hyperphosphorylated peptides that is suitable for further
label-free quantitative analysis. In addition to the candidate
hyperphosphorylated peptides, we also further analyzed all
known or predicted PP1 interacting proteins (29 proteins),
proteins encoded by genes essential for male fertility (40
proteins), and proteins associated with the GO biological pro-
cess Reproduction (33 proteins) that were identiﬁed in our
phosphoproteomic dataset, as well as proteins identiﬁed in
SBP-3XFLAG-PPP1CC2 ES cell tandem afﬁnity puriﬁcation [20].
In total phosphopeptides from233different proteinswere sub-
jected to extracted ion chromatogram quantitative analysis[34]. Skyline was used to select and align MS peaks with inte-
grated MS/MS and retention time data from which area under
the curve (AUC) valueswere calculated. Log2 transformedAUC
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Table 2 – Candidate PPP1CC2 substrates. Shown is a list of identiﬁed phosphopeptides signiﬁcantly more abundant in 3 week old Ppp1cc knockout testes than in
wild-type. Gene names followed by * indicate an infertility phenotype in knockout mice. Mut/WT XIC AUC is calculated based on raw values for clarity, while t-tests
were performed using log2 transformed values.
Accession Gene name Peptide sequence GO biological process Localized
phosphorylation site
Ascore Mut/WT XIC AUC t-Test
Q9JIX6 Acin1 HLpSHPEPEQQHVIQR Apoptotic process S656 1000 2.6 0.020
Q8K019 Bclaf1 QKFHDpSEGDDTEETEDYR Transcription S395 56.76 1.6 0.036
Q9CXS4 Cenpv pSGATGGLSGGESR Cell cycle S18 26.79 1.8 0.028
Q8JZQ9 Eif3b AKPAAQSEEETATpSPAApSPTPQSAER Translation S75, S79 51.64, 20.17 2.3 0.039
Q9D824 Fip1l1 DHp(SPT)PSVFNpSDEERYR mRNA processing S487 123.86 3.7 0.014
E9Q0C6 Gm14569 p(SISHDSVFCLDPEPEKGAGK) N/A 2.0 0.028
P17095 Hmga1* KLEKEEEEGISQESSEEEQ Transcription S99, S102, S103 1000, 1000, 1000 3.0 0.024
Q3U2G2 Hspa4* HAEQNGPVDGQGDNPGpSQAAEHGADTAVPSDGDK Tesponse to stress S817 23.91 2.2 0.041
Q6ZQ58 Larp1 DGAEREpSPRPPAAAEAPAGpSDGEDGGRR Macroautophagy S68, S81 1000, 1000 3.0 0.045
Q05CL8 Larp7 pp(TASEGSEAETPEAPKQPAK) RNA processing 4.3 0.052
P97820 Map4k4 RDpSPLQGGGQQNSQAGQR Protein phosphorylation S587 78.73 2.2 0.029
Q9R0L6 Pcm1 pp(NVRSDVSDQEEDEESERCPVSINLSK) Centrosome organization 12.9 0.045
Q3UHX2 Pdap1 SLDpSDEpSEDEDDDYQQK N/A S60, S63 20.05, 63.94 4.1 0.045
Q99JF8 Psip1 p(QSNAS)pSDVEVEEK Transcription S106 32.40 3.2 0.023
Q99JF8 Psip1 NLAKPGVTSTpSDpSEDEDDQEGEKK Transcription S272, S274 34.27, 59.30 3.9 0.043
Q8K094 Pvr ENVQYSpSVNGDCR Cell–cell adhesion S393 20.35 3.0 0.042
Q9ERD6 Ralgps2 SSAAAAAAAAAEGALLPQpTPPpSPR Small GTPase mediated signal
transduction
T333, S336 187.35, 181.18 4.0 0.015
Q64012 Raly LPAPQEDpTASEAGpTPQGEVQTR mRNA processing T268, T274 55.44, 26.42 2.6 0.046
Q9ERU9 Ranbp2 pQNQPTSCVSAPAp(SSETSRSPK) Protein transport 2.2 0.032
Q5U4C3 Scaf1 APpSPAPAVpSPK mRNA processing S676, S682 1000, 1000 5.9 0.007
Q99NB9 Sf3b1 KLSSWDQAEpTPGHpTPSLR mRNA processing T223, T227 21.77, 25.37 5.2 0.037
Q8BP27 Sfr1 pp(ENPPSPPTSPAAPQPR) DNA repair 2.3 0.050
Q52KI8 Srrm1 KEpTEpSEAEDDNLDDLER mRNA processing T876, S878 1000, 1000 4.0 0.037
Q8BTI8 Srrm2 ARpSRpTPPSAPSQSR mRNA processing S2264, T2266 103.22, 126.91 1.7 0.047
Q9CUU3 Sycp2* p(SLS)PYPKAPpSPEFLNGNNSVVGR Meiosis S1124 84.11 3.4 0.030
Q9CUU3 Sycp2* p(LVNPLELGNSSSQDEITpTPSR) Meiosis T464 21.30 2.3 0.030
Q8BYJ6 Tbc1d4 HAp(SAPS)HVQPSDSEK Vesicle-mediated transport 2.0 0.014
Q569Z6 Thrap3 WAHDKFpSGEEGEIEDDEp(SGTENREEK) RNA splicing S924 42.02 4.1 0.036
P39447 Tjp1 pSREDLSAQPVQTK Negative regulator of vascular
permeability
S617 17.48 3.3 0.029
P83510 Tnik ANpSKp(SEGSPVLPHEPSK) Protein phosphorylation S735 21.77 5.2 0.043
G5E870 Trip12 VREDDEDpSDDDGpSDEEIDESLAAQFLNSGNVR DNA repair S1350, S1355 27.86, 43.65 12.9 0.037
B2RUF0 Ybx2* pTPGNQATAASGpTPAPPAR Spermatid development T66, T77 40.19, 40.28 2.9 0.045
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Fig. 5 – Distribution of spectral counting and MS/MS peak XIC data for wild-type and Ppp1cc mutant testis phosphopeptides.
(A) Spectral counting of individual phosphorylation sites. The solid line indicates an equal spectral count in each genotype,
while dashed lines indicate a 2-fold increase in either genotype. (B) XIC of MS/MS peaks of individual phosphopeptides.
X-axis represents a log2 transformation of the Ppp1cc mutant/wild-type ratio of extracted ion chromatogram area under the
curve values. Y-axis is the untransformed sum of the average extracted ion chromatogram area under the curve values for
wild-type and Ppp1cc samples for a given peptide observed in at least 2 of 3 replicates of each genotype.values were then subjected to statistical analysis via a stu-
dent’s t-test and peptides displaying a statistically signiﬁcant
(p≤0.05) increase in abundance were identiﬁed. This yielded
the identiﬁcation of 32 different peptides in 30 proteins that
were signiﬁcantly more abundant in the 3 week Ppp1ccmutant
testis (Table 2). A representative example of a peptide from
TBC1D4 is depicted in Fig. 6. The average fold-change in these
peptides is 3.7 with a lowest signiﬁcant fold-change of 1.6 and
Table 3 – GO biological processes and molecular functions enric
mouse background dataset. Data from DAVID Functional Annot
Biological process/molecular function
mRNA metabolic process
mRNA processing
RNA processing
RNA splicing
RNA binding
RNA splicing factor activity, transesteriﬁcation mechanismahighest of 12.9. Amongst the identiﬁedhyperphosphorylated
proteins, 4 are encoded by genes which are essential for male
fertility – HMGA1, HSPA4, SYCP2 and YBX2 and one known PP1
substrate, SF3B1 (Fig. 7). Additionally one predicted PP1 inter-
acting protein HSPA4 was hyperphosphorylated (Fig. 7). As all
of these proteins have phosphorylation sites that are more
abundant in Ppp1cc mutant testes, they all represent candi-
date PPP1CC2 substrates in the testis. Gene ontology analysis
hed in the hyperphosphorylated dataset relative to a full
ation Tool.
Proteins (no.) p-Value
7 1.10E−05
6 8.10E−05
7 8.81E−05
5 3.9E−04
7 7.9E−04
2 1.0E−02
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Fig. 6 – Example of Skyline MS1 ﬁltering output. Skyline MS1 ﬁltering identiﬁed a peptide HAp(SAPS)HVQPSDSEK(which
maps to TBC1D4) that was more abundant in Ppp1cc mutant testis samples than in wild-type. (A) Histogram showing XIC
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evealed several biological processes and molecular functions
o be signiﬁcantly enriched in this set of genes, all of which
nvolve RNA processing (Table 3).
A large portion (approximately 90%) of all currently known
IPs contain a short degenerate RVxF docking motif ([KR]-
(0,1)-[VI]-{P}-[FW]) which is the principal site of interaction
ith the phosphatase. However, as a caveat, the presence of
his motif does not prove interaction with PP1 isoforms, as the
otif is frequently observed throughout the proteome (∼25%
f all proteins). In many instances, PIPs are thought to act as
egulatory subunits by binding to the RVxF motif, targeting
P1 catalytic subunits to dephosphorylate speciﬁc substrates.
owever, this is not always the case, as many known PP1
ubstrates also contain RVxF motifs [46]. Fourteen of the 32
45%) candidate PPP1CC2 substrate proteins identiﬁed in this
tudy contain RVxF motifs (31 instances). PP1 docking motifs
ften reside in ﬂexible, exposed surface regions of proteins as
pposed to inside globular domains [39,47]. Ignoring instancess for selected peaks across all 6 replicates.
of RVxF motifs inside globular domains, there remain four
candidate PPP1CC2 substrate proteins with predicted acces-
sible docking motifs – PVR, RANBP2, SRRM2, and TBC1D4. The
presence of this motif in an accessible region of a substrate
protein may be indicative of a stronger association with the
phosphatase catalytic subunit than is typical of PP1 substrates.
4. Discussion
In a landmark study, Bellve et al. [48] isolated and charac-
terized the cell type composition of the prepubertal mouse
testis throughout the ﬁrst 20 days of postnatal life. The ﬁrst
wave of mouse spermatogenesis begins one week post-natal
(p.n.). Until that point, the only germ cells present in the
testis are Spermatogonia (Type A at six days p.n. and Types
A and B at eight days p.n.). By day 10, meiosis has begun,
with preleptotene and leptotene spermatocytes ﬁrst being
12 e u pa open proteomics 2 ( 2 0 1 4 ) 1–16
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Fig. 7 – Quantitative comparison of XIC peak areas of hyperphosphorylated phosphopeptides mapping to genes essential
for spermatogenesis (HMGA1, YBX2, HSPA4, SYCP2) and a known PP1 substrate (SF3B1). Bars represent average XIC peak
ard eareas across 3 biological replicates of each genotype ±stand
observed. Subsequently, zygotene and early pachytene sper-
matocytes are ﬁrst found at days 12 and 14, respectively.
Developing germ cells reach the late pachytene stage between
days 18 and 20. Day 20 marks the completion of the ﬁrst wave
of meiosis, with secondary spermatocytes and the ﬁrst round
spermatids beginning to appear at this date. By four weeks
of age the mice are sexually mature, and a full complement
of germ cell types are found in the testis. To date, several
studies have examined the expression pattern of Ppp1cc1 and
Ppp1cc2 in the mouse testis, primarily at the protein level. An
early study by Takizawa et al. [10] performed western blots
on various mouse tissues for PP1 isoforms and found that
both PPP1CC isoforms, as well as PPP1CA and PPP1CB were
expressed in the mature mouse testis, with PPP1CC2 being
expressed at a very high level. Another study, by Chakrabarti
et al. [49] found that both PPP1CC1 and PPP1CC2 were both
detectable in the mouse testis at eight days p.n. via western
blot (the ﬁrst time point examined) and that the PPP1CC2 pro-
tein level increased between the ages of 8 and 30 days p.n.
indicating a higher degree of PPP1CC2 expression in later stage
germ cells. This is consistent with our qPCR data, which is an
important conﬁrmation as the correlation betweenmRNAand
protein levels can often be poor in the testis [50]. Immuno-
histochemical (IHC) analysis of PPP1CC2 in the mouse testis
shows high PPP1CC2 expression in all germ cell stages from
primary spermatocytes onwards, with lower expression lev-
els in spermatogonia as well as in the somatic Sertoli cells
[14]. PPP1CC1 has been observed via IHC to be expressed at
low levels in all germ cell stages, as well as in at higher lev-
els in interstitial cells [48]. Analysis of PPP1CA expression in
the testis has shown expression throughout spermatogene-
sis, including in condensing spermatids [7]. In the existingrror.
body of literature of PP1s in the testis, there have been mul-
tiple claims that PPP1CC2 is the only PP1 isoform present in
mammalian spermatozoa; however, several proteomic stud-
ies indicate that this is not actually the case [51–53]. It is
apparent from these previous works that PP1 isoforms are dif-
ferentially expressed in the mouse testis [7,10,49]. However,
studies such as immunohistochemistry and Western blots are
only semi-quantitative at best, and can lead to discrepancies
in descriptions in expression patterns. The results of our study
prove deﬁnitively that the expression of the Ppp1cc2 isoform
is speciﬁcally upregulated beginning at 3 weeks of age.
To date, a large portion of the research regarding PPP1CC2’s
role in mammalian spermatogenesis has focused on a later
established role in motility, but it is clear that PPP1CC2 is ﬁrst
required much earlier in spermatogenesis. Histological exam-
ination of developing Ppp1cc mutant testes has conﬁrmed
previous observations [25] that the earliest phenotypic effects
of this mutation are visible by 3 weeks of age, correspond-
ing to upregulation of the Ppp1cc2 isoform. At this age, many
seminiferous tubules retain normal architecture, however,
others are beginning toprematurely shedgermcells, and show
signs of seminiferous tubule degeneration. In order to learn
more about the function(s) of PPP1CC2 at this stage in sper-
matogenesis, this study sought to identify candidate PPP1CC2
substrates via a comparative phosphoproteomic analysis at a
stage when minimal cellular differences between mutant and
wild type would be expected to confound results. For an infor-
mative comparison to be made, this time point was pivotal.The experiments described in this study represent to our
knowledge, the largest comparative analysis of the mouse
testis phosphoproteome under pathologic (i.e. mutant) condi-
tions to date. Previous large-scale analyses of different mouse
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issues have produced two very large testis phosphoproteome
atasets [1,2], including one of the three week testis; how-
ver, these experiments focused on tissue–tissue variation as
pposed to an examination of the testis under pathological
i.e. mutant) conditions. Despite the size of these datasets
lmost 1/4 of the phosphoprotein gene symbols identiﬁed in
ur dataset were not listed in the 3 week testis by Huttlin
t al. Differences in the formattingof results likely accounts for
ome of the variation, as conversion between different types
f gene/protein identiﬁers can be problematic. Similarly, at the
eptide level, approximately 1/4 of the 1578 unique peptides in
ur dataset (ignoring phosphorylation site assignment) were
ot identiﬁed by Huttlin et al. including 7 of the 32 hyper-
hosphorylated testis peptides (mapping to BCLAF1, GM14569,
SPA4, ACIN1, LARP1, TBC1D4 and PVR). One potential reason
or this is differences in the phosphopeptide enrichment strat-
gy; Huttlin employed only IMAC, while we used both IMAC
nd TiO2 chromatography. It has been established experimen-
ally that each phosphopeptide enrichment strategy isolates
distinct overlapping fraction of the total phosphoproteome
54]. This illustrates that, while phosphoproteomic datasets
ontinue to increase in size, covering the entire phosphopro-
eome by any one method is currently not technically feasible.
hen our dataset is compared to the previous phosphopro-
eomic dataset from our lab, only 7 proteins were common to
oth sets, and none identiﬁed as being more abundant in 3
eek Ppp1cc mutant testes [17]. This lack of overlap is likely
ue to several factors. First the previous dataset is small (only
7 proteins) and many of the proteins were identiﬁed from
el spots picked from 2-D gels after phospho-speciﬁc staining,
hat contained multiple proteins, and thus may not even be
hosphorylated. In addition, this experiment was conducted
sing adult testes which contain cell types and therefore pro-
eins/phosphorylation events not present in the 3 week testis.
Our testis phosphoproteome data, the product of efﬁ-
ient phosphopeptide enrichment, displays reproducible
rotein/peptide identiﬁcation, making it possible to per-
orm an informative comparison of the wild-type and Ppp1cc
utant phosphoproteomes. To identify phosphopeptides that
ere more abundant in the Ppp1cc mutant testis, we utilized
combination of multiple label-free quantitation methods.
hile many quantitative proteomic and phosphoproteomic
tudies use metabolic labeling strategies such as SILAC, label-
ree methods can provide a powerful alternative that is often
ore suitable to tissue samples frommammalianmodels. Our
nalysis strategy consisted of two stages (Fig. 4) inwhich a pre-
iminary semi-quantitative analysis was used to develop a list
f peptides for further, more rigorous quantitative analysis.
he use of a two stage analytical strategywas helpful in reduc-
ng the amount of data processing in the MS1 ﬁltering stage.
hile Skyline automatically assigns and aligns MS peaks,
anual inspection of these data for each peptide was per-
ormed to ensure that accurate retention times were selected
or alignment. By only performing a semi-quantitative anal-
sis on a large portion of the data, it could be argued that
signiﬁcant amount phosphoproteomic data was not thor-ughly analyzed quantitatively. However, we feel that our two
tage analytical strategy allowed us to extract the strongest
andidate PPP1CC2 substrates from our dataset whilst reduc-
ng the amount of data processing needed.2 ( 2 0 1 4 ) 1–16 13
Our quantitative phosphoproteomic analysis of the mouse
testis identiﬁed 32 different peptides in 30 proteins that were
more abundant in 3weekold Ppp1ccmutantswhichmay repre-
sent candidate PPP1CC2 substrates. The fact that we identiﬁed
a known PP1 substrate, SF3B1 as being hyperphosphorylated
via this method serves as an indicator that our technique is
capable of identifying true PP1 substrates. As a caveat, our
data does not demonstrate direct dephosphorylation of any of
these proteins by PPP1CC2, but instead provides a strong list
of candidates for further study. Previous phosphoproteomic
studies have demonstrated that there are thousands of phos-
phorylated proteins in the mouse testis, even at 3 weeks of age
[1]. Furthermore, interactions between PP1 catalytic subunits
and their substrates are oftenweakand transient,making sub-
strate identiﬁcation based on interaction studies challenging.
For these reasons, we feel that our study represents an impor-
tant step in the substrate identiﬁcation process by developing
a list of candidate PPP1CC2 substrates that is of a suitable
length to test individually over the course of future studies. A
similar experimental approach was previously used to iden-
tify candidate substrates of PP5 in HeLa cells [55]. As is the
case for many quantitative phosphoproteomic studies, it is
difﬁcult to discern instances of true hyperphosphorylation
from differences in protein abundance due to the fact that so
few unique peptides are isolated for each individual protein.
It is likely that some of these observed changes in phos-
phopeptide abundance derive from indirect effects secondary
to the loss of Ppp1cc in the testis. However, by performing
our phosphoproteomic analysis at the time point where the
earliest, and therefore most subtle, phenotypic changes are
observed, we have kept these instances to a minimum. Most
of the candidate PPP1CC2 substrates identiﬁed (23/31) were
represented by more than one unique phosphopeptide in our
dataset. For all but two of these proteins (TJP1 and LARP7)
these additional peptides did not appear to show increased
abundance in Ppp1cc mutants, indicating the likelihood of
hyperphosphorylation at the speciﬁc site(s) indicated. Seven
of the candidate PPP1CC2 substrate proteins (CENPV, LARP1,
MAP4K4, PVR, RANBP2, SCAF1, and TBC1D4) were represented
by a single unique peptide and we were therefore unable to
rule out changes in protein abundance. Future studies eval-
uating all of these candidate substrates should ﬁrst aim to
rule out this alternate explanation using techniques such as
western blotting or quantitative mass spectrometry of non-
phosphopeptide enriched samples. Nonetheless, it is worth
noting that even indirect misregulation of the phosphoryla-
tion status or abundance of proteins can provide information
regarding pathways or processes affected by the loss of Ppp1cc
in the testis.
As mentioned above, amongst the identiﬁed candidate
testis substrates is one known PP1 substrate, SF3B1 (Splic-
ing factor 3B subunit 1). This protein, associated with the
U2 snRNP complex in the spliceosome, is essential early
in the pre-mRNA splicing reaction, and has been shown to
be phosphoregulated throughout that process speciﬁcally on
a series of Thr/Pro motifs in a TP-rich domain [56]. The
hyperphosphorylated SF3B1 peptide identiﬁed in this study
shows two such sites of threonine phosphorylation (KLSS-
WDQAEpTPGHpTPSLR). One previous study demonstrated
that PP1 was targeted to dephosphorylate SF3B1, (otherwise
omic
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known as SAP155) by the NIPP1 (PPP1R8) regulatory subunit
[42]. Furthermore, the results suggested that de-regulation of
SF3B1 phosphorylation was sufﬁcient to perturb the splicing
reaction [42]. In the developing mouse testis SF3B1 protein
is found to be ubiquitously expressed in the seminiferous
tubules at both 6 and 35 days after birth [57]. The same
study also found that phosphorylated SF3B1 was preferen-
tially associated with chromatin indicating that during testis
development the spliceosome contains phosphorylated SF3B1
which is active in pre-mRNA splicing at that time. Thus
hyperphosphorylation of SF3B1 due to a loss of PPP1CC2
during testis development could lead to a disruption of the
splicing process and affect gene expression in spermatogene-
sis. This seems to be a plausible explanation for the Ppp1cc
mutant phenotype, given the variety of abnormalities seen
in this background. In addition, our gene function analysis
of the hyperphosphorylated proteins identiﬁed in this study
revealed that proteins involved in mRNA processing and splic-
ing were enriched, which may indicate a general disregulation
of these processes in Ppp1cc mutants. One can thus envision
that a loss of PPP1CC2 activity towards one speciﬁc protein,
SF3B1, could lead to secondary hyperphosphorylation of other
components of mRNA processing pathways. In support of
this model, one recent study in infertile human patients with
severe oligozoospermia found a number of cases with splic-
ing defects in the UBE2E gene, demonstrating that defects
mRNA editing and splicing can lead to infertility [58]. Based
on these results, it was suggested that post-transcriptional
mRNA defects may play a greater role in infertility than had
previously been apparent.
Aside from SF3B1, two additional candidate substrates
have links to PP1 via shared interacting proteins – SRRM1
(TRA2B), and TJP1 (OCLN). TJP1, which is important in the reg-
ulation and maintenance of the Sertoli-cell junctions in the
testis [59] also associates with one of the other hyperphos-
phorylated proteins identiﬁed in this study – HSPA4 (data from
Uniprot database www.uniprot.org). However, ultrastructural
analysis of Ppp1cc mutant testes did not reveal any obvious
defects in several different junctional complexes [9]. Several
of the candidate PPP1CC2 substrates identiﬁed in this study
are known to be essential for spermatogenesis. Targeted dele-
tion of Hspa4 results in male speciﬁc infertility due to a partial
arrest in prophase I of meiosis, resulting in widespread apo-
ptosis in late pachytene spermatocytes [60]. This phenotype
has many similarities to the Ppp1cc mutant phenotype with
widespread loss of developing germ cell populations, the pres-
ence of immature germ cells in the epididymis and defects
in chromatin condensation; however, the most severe loss
of germ cells occurs slightly earlier in Hspa4 knockouts than
in Ppp1cc [7,60]. The Hspa4 mutant phenotype is also highly
similar to that of Hspa2 [61] which was previously identi-
ﬁed as a candidate PPP1CC2 substrate and interactor and
was shown to be abnormally distributed in Ppp1cc mutant
spermatogenic cells [17]. Chimeric mice harboring a dele-
tion of another hyperphosphorylated testis protein HMGA1
were also observed to have disrupted spermatogenesis, with
widespread loss of germ cells beginning with spermatocytes,
resulting in azoospermia [62]. SYCP2 is a component of the
synaptonemal complex during meiosis, and targeted dele-
tion of this gene results in a complete meiotic arrest [63].s 2 ( 2 0 1 4 ) 1–16
Recent research has demonstrated that many proteins in the
meiotic chromosome axis, including SYCP2 become phos-
phorylated during prophase I of spermatogenesis and it has
been hypothesized that phosphorylation is important in reg-
ulating chromosomal events at this juncture [64]. Deletion
of another candidate PPP1CC2 substrate gene, Ybx2 (Msy2)
results in the complete absence of mature sperm in male mice
due to abnormalities in both meiotic and post-meiotic cells
[65]. Ybx2 knockout seminiferous tubules display an increase
in apoptosis in spermatocytes, and later a block in sper-
matid elongation. Multinucleated spermatids were frequently
observed, as were abnormally shaped and variably condensed
spermatid nuclei, features that are also observed in Ppp1cc
mutants [7,65]. Aside from the above-mentioned proteins that
are encoded by genes shown to be essential for spermatogen-
esis, several other candidate PPP1CC2 substrates identiﬁed in
this study have also been linked to spermatogenesis: LARP7
[66], PSIP1 [67], PVR [68] and RANBP2 [69].
Spermatogenesis is a complex developmental process
involving the coordination of hundreds, if not thousands, of
proteins. While the identities of many of these proteins are
known, the speciﬁc roles they play, and how they are regu-
lated remains, in most cases, unknown. The results of this
study will help to shed some light on the role of one of these
proteins, the testis speciﬁc protein phosphatase PPP1CC2. Our
comparative phosphoproteomic analysis of the Ppp1cc mutant
testis has produced a list of candidate substrates of a practical
length for future analysis, including a number of proteinswith
known or potential links to spermatogenesis. Future stud-
ies will seek to verify which of these candidates are direct
PPP1CC2 substrates, and determine their roles in the regula-
tion of mammalian spermatogenesis.
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